Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study

Respir Res. 2020 Aug 21;21(1):220. doi: 10.1186/s12931-020-01473-2.

Abstract

Reflux of gastric content has been associated with recurrent exacerbations of chronic obstructive pulmonary disease (COPD). We aimed to assess the prevalence of laryngopharyngeal reflux (LPR) in COPD and if LPR is a contributing factor to clinically relevant outcomes in COPD. We evaluated a total of 193 COPD patients (GOLD I-IV) with a 24-h laryngo-pharyngeal pΗ-monitor. LPR was observed in 65.8% of COPD patients and it was not significantly associated with clinically relevant outcomes of COPD. Treatment with PPI significantly decreased the upright RYAN score (p = 0.047) without improving lung function. Furthermore, the presence or severity of LPR cannot be diagnosed based solely on symptoms and questionnaires.

Keywords: Chronic obstructive pulmonary disease; Gastroesophageal reflux; Laryngopharyngeal reflux; Proton pump inhibitor therapy; RYAN score.

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Laryngopharyngeal Reflux / diagnosis*
  • Laryngopharyngeal Reflux / epidemiology*
  • Laryngopharyngeal Reflux / physiopathology
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive / diagnosis*
  • Pulmonary Disease, Chronic Obstructive / epidemiology*
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Respiratory Function Tests / methods*
  • Surveys and Questionnaires*